Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last C$0.03 CAD
Change Today -0.02 / -40.00%
Volume 48.8K
As of 10:11 AM 08/31/15 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

701 West Georgia Street

Suite 1500

Vancouver, BC V7Y 1C6


Phone: 604-436-4388

Fax: 604-436-4380

Pacgen Life Science Corporation, a life science technology company, focuses on the commercialization of biomedical products and services. It offers lab equipment, such as Fit X1 401, an automated, high-precision pipetting system designed to replace the manual process of PCR/qPCR sample preparation; electronic pipettes; and A + Pipette Controller, an electronic pipette controller designed for use with graduated and volumetric glass and plastic pipets. The company also provides reagent kits. In addition, it develops novel therapeutic drug candidates. Its product candidates include PAC-113, an anti-fungal drug, which has completed a Phase IIb clinical trial for the treatment of oral Candidiasis; and PAC-G31P, a novel peptide therapeutic, which is in preclinical studies for the treatment of inflammatory diseases characterized by non-beneficial neutrophil. The company has license agreement with Demegen, Inc. to expand its exclusive worldwide rights and license to PAC-113 for additional indications, including vaginal, dermatological, and ophthalmic applications. It was formerly known as Pacgen Biopharmaceuticals Corporation and changed its name to Pacgen Life Science Corporation in April 2012. The company was founded in 2004 and is headquartered in Vancouver, Canada.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PBS:CN C$0.03 CAD -0.02

PBS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for PBS.
View Industry Companies

Industry Analysis


Industry Average

Valuation PBS Industry Range
Price/Earnings 100.0x
Price/Sales 38.1x
Price/Book 33.5x
Price/Cash Flow 4,264.8x
TEV/Sales 34.0x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PACGEN LIFE SCIENCE CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at